EMBX (EMBX) Stock Price & Analysis
EMBX (EMBX) rose 0.02% to USD 50.72 as of July 25, 2026 at 19:42 UTC, according to Nexqual real-time market data.
EMBX last closed at USD 50.71; the session ranged USD 50.71–50.76 on volume of 16,220 shares. Market capitalization is —, with a 52-week range of USD 48.32–54.61 (PCX). Source: Nexqual, July 25, 2026 at 19:42 UTC.
Key Statistics (as of July 25, 2026 at 19:42 UTC)
| Price | USD 50.72 |
|---|---|
| Change | ▲ 0.02% (up) |
| Previous Close | USD 50.71 |
| Open | USD 50.73 |
| Day Range | USD 50.71 – 50.76 |
| 52-Week Range | USD 48.32 – 54.61 |
| Volume | 16,220 shares |
| Market Cap | — |
| Exchange | PCX |
Technical Analysis (EMBX)
Nexqual's technical model rates EMBX "STRONG SELL" based on 0 bullish and 5 bearish signals across 125 daily candles, as of July 25, 2026 at 19:42 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 42.28 (neutral) |
| vs SMA50 | Below (USD 51.19) |
| MACD | -0.12 (negative) |
Financial Health Score (EMBX)
Nexqual rates EMBX's overall financial health "Mixed" across five dimensions, as of July 25, 2026 at 19:42 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Mixed — No data |
| Balance Sheet | Mixed — No data |
| Cash Flow | Mixed — No data |
| Efficiency | Mixed — No data |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| GCOR | Goldman Sachs Access U.S. Aggre | USD 40.55 | ▼ 0.11% |
| DUSA | Davis Select U.S. Equity ETF | USD 56.93 | ▼ 0.85% |
| EMIS | Emmis Acquisition Corp. | USD 10.19 | ▲ 0.1% |
| GTOP | Goldman Sachs Technology Opport | USD 46.66 | ▼ 3.06% |
| NTII | NEUROBIOLOGICAL TECHNOLOGIES IN | USD 0 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 19:42 UTC. This page is informational and not investment advice.